Lexaria Bioscience Corp

NASDAQ:LEXX

0.88

-0.02 (-2.12%)

4:32:54 PM EDT: $0.90 +0.02 (+2.17%)

Market Cap (Intraday)	16.80M
Current PE	N/A
Forward PE	N/A
2yr Forward PE	N/A

See more stats

Estimates Current Quarter

Revenue	$0.17 Million
Adjusted EPS	-$0.16

See more estimates

10-Day MA	$0.89
50-Day MA	$0.99
200-Day MA	$1.80

See more pivots

Lexaria Bioscience Corp Stock, NASDAQ:LEXX

740 McCurdy Road, Suite 100, Kelowna, British Columbia V1X 2P7

Canada

Phone: +1.250.765.6424

Number of Employees: 7

http://www.lexariabioscience.com

Description

Lexaria Bioscience Corp. is a biotechnology company, which engages in the provision of active pharmaceutical ingredients through its DehydraTECH drug delivery technology. It operates through the following segments: IP Licensing, B2B Product, Research and Development, and Corporate. The company was founded on December 9, 2004 and is headquartered in Kelowna, Canada.